{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:56:36Z","timestamp":1790852196806,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Hong Kong RGC Fund","award":["16102522"],"award-info":[{"award-number":["16102522"]}]},{"name":"the Hong Kong ITC Fund","award":["ITCPD\/17-9"],"award-info":[{"award-number":["ITCPD\/17-9"]}]},{"name":"the National Key R&D Program of China","award":["2024YFA1306600"],"award-info":[{"award-number":["2024YFA1306600"]}]},{"name":"the National Science Foundation of China","award":["82571989"],"award-info":[{"award-number":["82571989"]}]},{"name":"the Hangzhou \u201cXHMZ\u201d Top Talent Program"},{"name":"the NSFC International Cooperation and Exchanges Program","award":["W2411067"],"award-info":[{"award-number":["W2411067"]}]},{"name":"the NSFC General Program","award":["82171267"],"award-info":[{"award-number":["82171267"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03950-9","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:52:57Z","timestamp":1783515177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CXCL13\u207a CD4\u207a T cells are associated with B-cell recruitment and lesion progression in cerebral cavernous malformations"],"prefix":"10.1186","volume":"23","author":[{"given":"Shaozhi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-1120","authenticated-orcid":false,"given":"Yong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"3950_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCRESAHA.121.318174","volume":"129","author":"DA Snellings","year":"2021","unstructured":"Snellings DA, Hong CC, Ren AA, Lopez-Ramirez MA, Girard R, Srinath A, Marchuk DA, Ginsberg MH, Awad IA, Kahn ML. Cerebral Cavernous Malformation: From Mechanism to Therapy. Circ Res. 2021;129:195\u2013215.","journal-title":"Circ Res"},{"key":"3950_CR2","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1056\/NEJMc2404443","volume":"390","author":"C Bourhila","year":"2024","unstructured":"Bourhila C, Levivier M, Tuleasca C. Cavernous Malformations of the Central Nervous System. N Engl J Med. 2024;390:2036.","journal-title":"N Engl J Med"},{"key":"3950_CR3","doi-asserted-by":"crossref","unstructured":"He Q, Huo R, Sun Y, Zheng Z, Xu H, Zhao S, Ni Y, Yu Q, Jiao Y, Zhang W et al. Cerebral vascular malformations: pathogenesis and therapy. MedComm (2020) 2024, 5:e70027.","DOI":"10.1002\/mco2.70027"},{"key":"3950_CR4","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1212\/WNL.0000000000002701","volume":"86","author":"S Taslimi","year":"2016","unstructured":"Taslimi S, Modabbernia A, Amin-Hanjani S, Barker FG 2nd, Macdonald RL. Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies. Neurology. 2016;86:1984\u201391.","journal-title":"Neurology"},{"key":"3950_CR5","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/2011.9.FOCUS11211","volume":"31","author":"RT Dalyai","year":"2011","unstructured":"Dalyai RT, Ghobrial G, Awad I, Tjoumakaris S, Gonzalez LF, Dumont AS, Chalouhi N, Randazzo C, Rosenwasser R, Jabbour P. Management of incidental cavernous malformations: a review. Neurosurg Focus. 2011;31:E5.","journal-title":"Neurosurg Focus"},{"key":"3950_CR6","doi-asserted-by":"crossref","unstructured":"Mouchtouris N, Chalouhi N, Chitale A, Starke RM, Tjoumakaris SI, Rosenwasser RH, Jabbour PM. Management of cerebral cavernous malformations: from diagnosis to treatment. ScientificWorldJournal 2015, 2015:808314.","DOI":"10.1155\/2015\/808314"},{"key":"3950_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ajhg.2021.04.005","volume":"108","author":"J Weng","year":"2021","unstructured":"Weng J, Yang Y, Song D, Huo R, Li H, Chen Y, Nam Y, Zhou Q, Jiao Y, Fu W, et al. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation. Am J Hum Genet. 2021;108:942\u201350.","journal-title":"Am J Hum Genet"},{"key":"3950_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-021-03562-8","volume":"594","author":"AA Ren","year":"2021","unstructured":"Ren AA, Snellings DA, Su YS, Hong CC, Castro M, Tang AT, Detter MR, Hobson N, Girard R, Romanos S, et al. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature. 2021;594:271\u20136.","journal-title":"Nature"},{"key":"3950_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10456-023-09866-9","volume":"26","author":"R Huo","year":"2023","unstructured":"Huo R, Yang Y, Sun Y, Zhou Q, Zhao S, Mo Z, Xu H, Wang J, Weng J, Jiao Y, et al. Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation. Angiogenesis. 2023;26:295\u2013312.","journal-title":"Angiogenesis"},{"key":"3950_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1474-4422(07)70053-4","volume":"6","author":"P Labauge","year":"2007","unstructured":"Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol. 2007;6:237\u201344.","journal-title":"Lancet Neurol"},{"key":"3950_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature22075","volume":"545","author":"AT Tang","year":"2017","unstructured":"Tang AT, Choi JP, Kotzin JJ, Yang Y, Hong CC, Hobson N, Girard R, Zeineddine HA, Lightle R, Moore T, et al. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature. 2017;545:305\u201310.","journal-title":"Nature"},{"key":"3950_CR12","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1182\/blood.2021015350","volume":"140","author":"MA Globisch","year":"2022","unstructured":"Globisch MA, Onyeogaziri FC, Jauhiainen S, Yau ACY, Orsenigo F, Conze LL, Arce M, Corada M, Smith RO, Rorsman C, et al. Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation. Blood. 2022;140:2154\u201369.","journal-title":"Blood"},{"key":"3950_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00018-022-04224-2","volume":"79","author":"ACY Yau","year":"2022","unstructured":"Yau ACY, Globisch MA, Onyeogaziri FC, Conze LL, Smith R, Jauhiainen S, Corada M, Orsenigo F, Huang H, Herre M, et al. Inflammation and neutrophil extracellular traps in cerebral cavernous malformation. Cell Mol Life Sci. 2022;79:206.","journal-title":"Cell Mol Life Sci"},{"key":"3950_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.122.321129","volume":"131","author":"CC Lai","year":"2022","unstructured":"Lai CC, Nelsen B, Frias-Anaya E, Gallego-Gutierrez H, Orecchioni M, Herrera V, Ortiz E, Sun H, Mesarwi OA, Ley K, et al. Neuroinflammation Plays a Critical Role in Cerebral Cavernous Malformation Disease. Circ Res. 2022;131:909\u201325.","journal-title":"Circ Res"},{"key":"3950_CR15","doi-asserted-by":"crossref","unstructured":"Li Y, Srinath A, Alcazar-Felix RJ, Hage S, Bindal A, Lightle R, Shenkar R, Shi C, Girard R, Awad IA. Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation. Brain Sci 2023, 13.","DOI":"10.3390\/brainsci13091336"},{"key":"3950_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12974-022-02385-2","volume":"19","author":"C Castro","year":"2022","unstructured":"Castro C, Oyamada HAA, Cafasso M, Lopes LM, Monteiro C, Sacramento PM, Alves-Leon SV, da Fontoura Galv\u00e3o G, Hygino J, de Souza J, Bento CAM. Elevated proportion of TLR2- and TLR4-expressing Th17-like cells and activated memory B cells was associated with clinical activity of cerebral cavernous malformations. J Neuroinflammation. 2022;19:28.","journal-title":"J Neuroinflammation"},{"key":"3950_CR17","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1161\/STROKEAHA.108.538769","volume":"40","author":"C Shi","year":"2009","unstructured":"Shi C, Shenkar R, Du H, Duckworth E, Raja H, Batjer HH, Awad IA. Immune response in human cerebral cavernous malformations. Stroke. 2009;40:1659\u201365.","journal-title":"Stroke"},{"key":"3950_CR18","doi-asserted-by":"publisher","first-page":"922281","DOI":"10.3389\/fimmu.2022.922281","volume":"13","author":"T Tu","year":"2022","unstructured":"Tu T, Peng Z, Ren J, Zhang H. Cerebral Cavernous Malformation: Immune and Inflammatory Perspectives. Front Immunol. 2022;13:922281.","journal-title":"Front Immunol"},{"key":"3950_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3171\/JNS-07\/11\/1023","volume":"107","author":"C Shi","year":"2007","unstructured":"Shi C, Shenkar R, Batjer HH, Check IJ, Awad IA. Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation. J Neurosurg. 2007;107:1023\u20136.","journal-title":"J Neurosurg"},{"key":"3950_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jneuroim.2014.04.016","volume":"272","author":"C Shi","year":"2014","unstructured":"Shi C, Shenkar R, Kinloch A, Henderson SG, Shaaya M, Chong AS, Clark MR, Awad IA. Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations. J Neuroimmunol. 2014;272:67\u201375.","journal-title":"J Neuroimmunol"},{"key":"3950_CR21","doi-asserted-by":"publisher","first-page":"102469","DOI":"10.1016\/j.jaut.2020.102469","volume":"113","author":"D Zhang","year":"2020","unstructured":"Zhang D, Kinloch AJ, Srinath A, Shenkar R, Girard R, Lightle R, Moore T, Koskim\u00e4ki J, Mohsin A, Carri\u00f3n-Penagos J, et al. Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu. J Autoimmun. 2020;113:102469.","journal-title":"J Autoimmun"},{"key":"3950_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11481-016-9670-0","volume":"11","author":"C Shi","year":"2016","unstructured":"Shi C, Shenkar R, Zeineddine HA, Girard R, Fam MD, Austin C, Moore T, Lightle R, Zhang L, Wu M, et al. B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models. J Neuroimmune Pharmacol. 2016;11:369\u201377.","journal-title":"J Neuroimmune Pharmacol"},{"key":"3950_CR23","doi-asserted-by":"publisher","first-page":"9097","DOI":"10.1038\/s41467-024-52977-0","volume":"15","author":"Z Yang","year":"2024","unstructured":"Yang Z, Tian H, Chen X, Li B, Bai G, Cai Q, Xu J, Guo W, Wang S, Peng Y, et al. Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma. Nat Commun. 2024;15:9097.","journal-title":"Nat Commun"},{"key":"3950_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jhep.2019.09.031","volume":"72","author":"Y Li","year":"2020","unstructured":"Li Y, Tang L, Guo L, Chen C, Gu S, Zhou Y, Ye G, Li X, Wang W, Liao X, et al. CXCL13-mediated recruitment of intrahepatic CXCR5(+)CD8(+) T cells favors viral control in chronic HBV infection. J Hepatol. 2020;72:420\u201330.","journal-title":"J Hepatol"},{"key":"3950_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/pcmedi\/pbab020","volume":"4","author":"Q Ma","year":"2021","unstructured":"Ma Q, Chen Y, Qin Q, Guo F, Wang YS, Li D. CXCL13 expression in mouse 4T1 breast cancer microenvironment elicits antitumor immune response by regulating immune cell infiltration. Precis Clin Med. 2021;4:155\u201367.","journal-title":"Precis Clin Med"},{"key":"3950_CR26","doi-asserted-by":"crossref","unstructured":"Yang M, Lu J, Zhang G, Wang Y, He M, Xu Q, Xu C, Liu H. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer. J Immunother Cancer 2021, 9.","DOI":"10.1136\/jitc-2020-001136"},{"key":"3950_CR27","doi-asserted-by":"crossref","unstructured":"Hui L, Li Y, Huang M-k, Jiang Y-m, Liu T. CXCL13: a common target for immune-mediated inflammatory diseases. Clin Experimental Med 2024, 24.","DOI":"10.1007\/s10238-024-01508-8"},{"key":"3950_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ni.1789","volume":"10","author":"SA van de Pavert","year":"2009","unstructured":"van de Pavert SA, Olivier BJ, Goverse G, Vondenhoff MF, Greuter M, Beke P, Kusser K, H\u00f6pken UE, Lipp M, Niederreither K, et al. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat Immunol. 2009;10:1193\u20139.","journal-title":"Nat Immunol"},{"key":"3950_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3171\/jns.1994.80.3.0422","volume":"80","author":"JM Zabramski","year":"1994","unstructured":"Zabramski JM, Wascher TM, Spetzler RF, Johnson B, Golfinos J, Drayer BP, Brown B, Rigamonti D, Brown G. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 1994;80:422\u201332.","journal-title":"J Neurosurg"},{"key":"3950_CR30","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, Hao Y, Stoeckius M, Smibert P, Satija R. Comprehensive Integration of Single-Cell Data. Cell. 2019;177:1888\u2013e19021821.","journal-title":"Cell"},{"key":"3950_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"3950_CR32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, Qin S, Zhang L, Ouyang H, Du P, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184:792\u2013e809723.","journal-title":"Cell"},{"key":"3950_CR33","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat Protoc. 2020;15:1484\u2013506.","journal-title":"Nat Protoc"},{"key":"3950_CR34","doi-asserted-by":"crossref","unstructured":"Lin X, Ye L, Wang X, Liao Z, Dong J, Yang Y, Zhang R, Li H, Li P, Ding L et al. Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. Cancers (Basel) 2021, 13.","DOI":"10.3390\/cancers13153678"},{"key":"3950_CR35","doi-asserted-by":"crossref","unstructured":"Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A, Suzuki H, Hosoe Y, Furutake Y, Taki M et al. CXCL13-producing CD4\u2009+\u2009T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer. JCI Insight 2022, 7.","DOI":"10.1172\/jci.insight.157215"},{"key":"3950_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/25785826.2020.1781998","volume":"43","author":"H Yoshitomi","year":"2020","unstructured":"Yoshitomi H. CXCL13-producing PD-1(hi)CXCR5(-) helper T cells in chronic inflammation. Immunol Med. 2020;43:156\u201360.","journal-title":"Immunol Med"},{"key":"3950_CR37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621\u201363.","journal-title":"Annu Rev Immunol"},{"key":"3950_CR38","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1038\/s41467-018-06187-0","volume":"9","author":"H Yoshitomi","year":"2018","unstructured":"Yoshitomi H, Kobayashi S, Miyagawa-Hayashino A, Okahata A, Doi K, Nishitani K, Murata K, Ito H, Tsuruyama T, Haga H, et al. Human Sox4 facilitates the development of CXCL13-producing helper T cells in inflammatory environments. Nat Commun. 2018;9:3762.","journal-title":"Nat Commun"},{"key":"3950_CR39","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1158\/2159-8290.CD-19-0620","volume":"10","author":"N Muthalagu","year":"2020","unstructured":"Muthalagu N, Monteverde T, Raffo-Iraolagoitia X, Wiesheu R, Whyte D, Hedley A, Laing S, Kruspig B, Upstill-Goddard R, Shaw R, et al. Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma. Cancer Discov. 2020;10:872\u201387.","journal-title":"Cancer Discov"},{"key":"3950_CR40","doi-asserted-by":"crossref","unstructured":"Okawa T, Nagai M, Fujita S, Suzuki K, Nakata K, Miyajima R, Shiratori H, Komiyama S, Takahashi D, Kawamura YI et al. Identification and characterization of CXCL13 producers in bone tissue in response to fasting. Int Immunol 2026.","DOI":"10.1093\/intimm\/dxag005"},{"key":"3950_CR41","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1177\/0271678X221105995","volume":"42","author":"X Yang","year":"2022","unstructured":"Yang X, Dai Z, Gao C, Yin Y, Shi C, Liu R, Zhuge Q, Huang Y, Zhou B, Han Z, Zheng X. Cerebral cavernous malformation development in chronic mouse models driven by dual recombinases induced gene deletion in brain endothelial cells. J Cereb Blood Flow Metab. 2022;42:2230\u201344.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3950_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41374-018-0030-y","volume":"99","author":"HA Zeineddine","year":"2019","unstructured":"Zeineddine HA, Girard R, Saadat L, Shen L, Lightle R, Moore T, Cao Y, Hobson N, Shenkar R, Avner K, et al. Phenotypic characterization of murine models of cerebral cavernous malformations. Lab Invest. 2019;99:319\u201330.","journal-title":"Lab Invest"},{"key":"3950_CR43","doi-asserted-by":"publisher","first-page":"105642","DOI":"10.1016\/j.isci.2022.105642","volume":"25","author":"Z Dai","year":"2022","unstructured":"Dai Z, Li J, Li Y, Wang R, Yan H, Xiong Z, Wu S, Yang X, Lu D, Zhang D, et al. Role of pericytes in the development of cerebral cavernous malformations. iScience. 2022;25:105642.","journal-title":"iScience"},{"key":"3950_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00262-017-2083-y","volume":"67","author":"Y Wei","year":"2018","unstructured":"Wei Y, Lin C, Li H, Xu Z, Wang J, Li R, Liu H, Zhang H, He H, Xu J. CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. Cancer Immunol Immunother. 2018;67:261\u20139.","journal-title":"Cancer Immunol Immunother"},{"key":"3950_CR45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13046-021-01947-1","volume":"40","author":"A Tosi","year":"2021","unstructured":"Tosi A, Cappellesso R, Dei Tos AP, Rossi V, Aliberti C, Pigozzo J, Fabozzi A, Sbaraglia M, Blandamura S, Del Bianco P, et al. The immune cell landscape of metastatic uveal melanoma correlates with overall survival. J Exp Clin Cancer Res. 2021;40:154.","journal-title":"J Exp Clin Cancer Res"},{"key":"3950_CR46","doi-asserted-by":"publisher","first-page":"188799","DOI":"10.1016\/j.bbcan.2022.188799","volume":"1877","author":"B Wang","year":"2022","unstructured":"Wang B, Wang M, Ao D, Wei X. CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer. Biochim Biophys Acta Rev Cancer. 2022;1877:188799.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3950_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.lfs.2019.04.053","volume":"227","author":"M Hussain","year":"2019","unstructured":"Hussain M, Adah D, Tariq M, Lu Y, Zhang J, Liu J. CXCL13\/CXCR5 signaling axis in cancer. Life Sci. 2019;227:175\u201386.","journal-title":"Life Sci"},{"key":"3950_CR48","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41586-019-1276-2","volume":"570","author":"A Ardain","year":"2019","unstructured":"Ardain A, Domingo-Gonzalez R, Das S, Kazer SW, Howard NC, Singh A, Ahmed M, Nhamoyebonde S, Rangel-Moreno J, Ogongo P, et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019;570:528\u201332.","journal-title":"Nature"},{"key":"3950_CR49","doi-asserted-by":"crossref","unstructured":"Hsieh CH, Jian CZ, Lin LI, Low GS, Ou PY, Hsu C, Ou DL. Potential Role of CXCL13\/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer. Cancers (Basel) 2022, 14.","DOI":"10.3390\/cancers14020294"},{"key":"3950_CR50","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.autrev.2016.03.006","volume":"15","author":"R Milo","year":"2016","unstructured":"Milo R. Therapeutic strategies targeting B-cells in multiple sclerosis. Autoimmun Rev. 2016;15:714\u20138.","journal-title":"Autoimmun Rev"},{"key":"3950_CR51","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1126\/science.1061964","volume":"293","author":"B Schiemann","year":"2001","unstructured":"Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 2001;293:2111\u20134.","journal-title":"Science"},{"key":"3950_CR52","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1371\/journal.pbio.0030150","volume":"3","author":"T Okada","year":"2005","unstructured":"Okada T, Miller MJ, Parker I, Krummel MF, Neighbors M, Hartley SB, O\u2019Garra A, Cahalan MD, Cyster JG. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol. 2005;3:e150.","journal-title":"PLoS Biol"},{"key":"3950_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.immuni.2009.06.016","volume":"31","author":"D Gatto","year":"2009","unstructured":"Gatto D, Paus D, Basten A, Mackay CR, Brink R. Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses. Immunity. 2009;31:259\u201369.","journal-title":"Immunity"},{"key":"3950_CR54","doi-asserted-by":"publisher","first-page":"850998","DOI":"10.3389\/fimmu.2022.850998","volume":"13","author":"Z Pan","year":"2022","unstructured":"Pan Z, Zhu T, Liu Y, Zhang N. Role of the CXCL13\/CXCR5 Axis in Autoimmune Diseases. Front Immunol. 2022;13:850998.","journal-title":"Front Immunol"},{"key":"3950_CR55","doi-asserted-by":"publisher","first-page":"18203","DOI":"10.1038\/s41598-019-54845-0","volume":"9","author":"S Subhash","year":"2019","unstructured":"Subhash S, Kalmbach N, Wegner F, Petri S, Glomb T, Dittrich-Breiholz O, Huang C, Bali KK, Kunz WS, Samii A, et al. Transcriptome-wide Profiling of Cerebral Cavernous Malformations Patients Reveal Important Long noncoding RNA molecular signatures. Sci Rep. 2019;9:18203.","journal-title":"Sci Rep"},{"key":"3950_CR56","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1182\/blood-2004-02-0701","volume":"104","author":"HS Carlsen","year":"2004","unstructured":"Carlsen HS, Baekkevold ES, Morton HC, Haraldsen G, Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood. 2004;104:3021\u20137.","journal-title":"Blood"},{"key":"3950_CR57","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1084\/jem.20091258","volume":"207","author":"RA Stockton","year":"2010","unstructured":"Stockton RA, Shenkar R, Awad IA, Ginsberg MH. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med. 2010;207:881\u201396.","journal-title":"J Exp Med"},{"key":"3950_CR58","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIRCRESAHA.121.318173","volume":"129","author":"J Rustenhoven","year":"2021","unstructured":"Rustenhoven J, Tanumihardja C, Kipnis J. Cerebrovascular Anomalies: Perspectives From Immunology and Cerebrospinal Fluid Flow. Circ Res. 2021;129:174\u201394.","journal-title":"Circ Res"},{"key":"3950_CR59","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature12207","volume":"498","author":"L Maddaluno","year":"2013","unstructured":"Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, Ferrarini L, Orsenigo F, Papa E, Boulday G, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492\u20136.","journal-title":"Nature"},{"key":"3950_CR60","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/jnnp.71.2.188","volume":"71","author":"RE Clatterbuck","year":"2001","unstructured":"Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry. 2001;71:188\u201392.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3950_CR61","doi-asserted-by":"crossref","unstructured":"Pachner AR, Pike S, Smith AD, Gilli F. CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis. Biomolecules 2024, 14.","DOI":"10.3390\/biom14121541"},{"key":"3950_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12865-015-0068-1","volume":"16","author":"E Klimatcheva","year":"2015","unstructured":"Klimatcheva E, Pandina T, Reilly C, Torno S, Bussler H, Scrivens M, Jonason A, Mallow C, Doherty M, Paris M, et al. CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunol. 2015;16:6.","journal-title":"BMC Immunol"},{"key":"3950_CR63","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1172\/JCI67428","volume":"123","author":"C Gu-Trantien","year":"2013","unstructured":"Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A, Ravoet M, Le Buanec H, Sibille C, Manfouo-Foutsop G, et al. CD4\u207a follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 2013;123:2873\u201392.","journal-title":"J Clin Invest"},{"key":"3950_CR64","doi-asserted-by":"crossref","unstructured":"Li JP, Wu CY, Chen MY, Liu SX, Yan SM, Kang YF, Sun C, Grandis JR, Zeng MS, Zhong Q. PD-1(+)CXCR5(-)CD4(+) Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma. J Immunother Cancer 2021, 9.","DOI":"10.1136\/jitc-2020-002101"},{"key":"3950_CR65","doi-asserted-by":"crossref","unstructured":"Harrer C, Otto F, Radlberger RF, Moser T, Pilz G, Wipfler P, Harrer A. The CXCL13\/CXCR5 Immune Axis in Health and Disease-Implications for Intrathecal B Cell Activities in Neuroinflammation. Cells 2022, 11.","DOI":"10.3390\/cells11172649"},{"key":"3950_CR66","doi-asserted-by":"publisher","first-page":"110766","DOI":"10.1016\/j.celrep.2022.110766","volume":"39","author":"N Meednu","year":"2022","unstructured":"Meednu N, Rangel-Moreno J, Zhang F, Escalera-Rivera K, Corsiero E, Prediletto E, DiCarlo E, Goodman S, Donlin LT, Raychauduri S, et al. Dynamic spectrum of ectopic lymphoid B cell activation and hypermutation in the RA synovium characterized by NR4A nuclear receptor expression. Cell Rep. 2022;39:110766.","journal-title":"Cell Rep"},{"key":"3950_CR67","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature08226","volume":"460","author":"JP Pereira","year":"2009","unstructured":"Pereira JP, Kelly LM, Xu Y, Cyster JG. EBI2 mediates B cell segregation between the outer and centre follicle. Nature. 2009;460:1122\u20136.","journal-title":"Nature"},{"key":"3950_CR68","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.4049\/jimmunol.1101542","volume":"187","author":"D Gatto","year":"2011","unstructured":"Gatto D, Wood K, Brink R. EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center. J Immunol. 2011;187:4621\u20138.","journal-title":"J Immunol"},{"key":"3950_CR69","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/j.celrep.2017.02.005","volume":"18","author":"CR Smulski","year":"2017","unstructured":"Smulski CR, Kury P, Seidel LM, Staiger HS, Edinger AK, Willen L, Seidl M, Hess H, Salzer U, Rolink AG, et al. BAFF- and TACI-Dependent Processing of BAFFR by ADAM Proteases Regulates the Survival of B Cells. Cell Rep. 2017;18:2189\u2013202.","journal-title":"Cell Rep"},{"key":"3950_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","volume":"99","author":"D Long","year":"2019","unstructured":"Long D, Chen Y, Wu H, Zhao M, Lu Q. Clinical significance and immunobiology of IL-21 in autoimmunity. J Autoimmun. 2019;99:1\u201314.","journal-title":"J Autoimmun"},{"key":"3950_CR71","doi-asserted-by":"crossref","unstructured":"Zhang H, Cavazzoni CB, Podest\u00e0 MA, Bechu ED, Ralli G, Chandrakar P, Lee JM, Sayin I, Tullius SG, Abdi R et al. IL-21-producing effector Tfh cells promote B cell alloimmunity in lymph nodes and kidney allografts. JCI Insight 2023, 8.","DOI":"10.1172\/jci.insight.169793"},{"key":"3950_CR72","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/glia.22692","volume":"62","author":"N Esen","year":"2014","unstructured":"Esen N, Rainey-Barger EK, Huber AK, Blakely PK, Irani DN. Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. Glia. 2014;62:1452\u201362.","journal-title":"Glia"},{"key":"3950_CR73","doi-asserted-by":"publisher","first-page":"e1036","DOI":"10.1002\/ctm2.1036","volume":"12","author":"Q Li","year":"2022","unstructured":"Li Q, Cheng Y, Zhang Z, Bi Z, Ma X, Wei Y, Wei X. Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3. Clin Transl Med. 2022;12:e1036.","journal-title":"Clin Transl Med"},{"key":"3950_CR74","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1038\/s41593-024-01769-2","volume":"27","author":"J Chen","year":"2024","unstructured":"Chen J, Crouch EE, Zawadzki ME, Jacobs KA, Mayo LN, Choi JJ, Lin PY, Shaikh S, Tsui J, Gonzalez-Granero S, et al. Proinflammatory immune cells disrupt angiogenesis and promote germinal matrix hemorrhage in prenatal human brain. Nat Neurosci. 2024;27:2115\u201329.","journal-title":"Nat Neurosci"},{"key":"3950_CR75","unstructured":"Casta\u00f1eyra-Ruiz L, Latini A, Hanak BW, Muhonen M. The protease threshold: a conceptual framework for germinal matrix hemorrhage. Preprint at https:\/\/zenodo.org\/records\/18756488 (2026)."},{"key":"3950_CR76","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00701-006-0929-8","volume":"149","author":"M Fujimura","year":"2007","unstructured":"Fujimura M, Watanabe M, Shimizu H, Tominaga T. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2. Acta Neurochir (Wien). 2007;149:179\u201383. discussion 183.","journal-title":"Acta Neurochir (Wien)"},{"key":"3950_CR77","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jocn.2009.06.008","volume":"17","author":"A Bicer","year":"2010","unstructured":"Bicer A, Guclu B, Ozkan A, Kurtkaya O, Koc DY, Necmettin Pamir M, Kilic T. Expressions of angiogenesis associated matrix metalloproteinases and extracellular matrix proteins in cerebral vascular malformations. J Clin Neurosci. 2010;17:232\u20136.","journal-title":"J Clin Neurosci"},{"key":"3950_CR78","doi-asserted-by":"crossref","unstructured":"Hong CC, Tang AT, Detter MR, Choi JP, Wang R, Yang X, Guerrero AA, Wittig CF, Hobson N, Girard R et al. Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. J Exp Med 2020, 217.","DOI":"10.1084\/jem.20200140"},{"key":"3950_CR79","doi-asserted-by":"publisher","first-page":"763065","DOI":"10.3389\/fimmu.2021.763065","volume":"12","author":"MW Huang","year":"2021","unstructured":"Huang MW, Stock AD, Putterman C. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice. Front Immunol. 2021;12:763065.","journal-title":"Front Immunol"},{"key":"3950_CR80","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1378\/chest.11-0633","volume":"141","author":"GJ Baay-Guzman","year":"2012","unstructured":"Baay-Guzman GJ, Huerta-Yepez S, Vega MI, Aguilar-Leon D, Campillos M, Blake J, Benes V, Hernandez-Pando R, Teran LM. Role of CXCL13 in asthma: novel therapeutic target. Chest. 2012;141:886\u201394.","journal-title":"Chest"},{"key":"3950_CR81","doi-asserted-by":"crossref","unstructured":"Zhang S, Chen X, Jin E, Wang A, Chen T, Zhang X, Zhu J, Dong L, Sun Y, Yu C et al. The GSA Family in 2025: A Broadened Sharing Platform for Multi-omics and Multimodal Data. Genomics Proteom Bioinf 2025, 23.","DOI":"10.1093\/gpbjnl\/qzaf072"},{"key":"3950_CR82","doi-asserted-by":"publisher","first-page":"D28","DOI":"10.1093\/nar\/gkaf1172","volume":"54","author":"Database resources of the National Genomics Data Center","year":"2026","unstructured":"Database resources of the National Genomics Data Center. China National Center for Bioinformation in 2026. Nucleic Acids Res. 2026;54:D28\u201347.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03950-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03950-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03950-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:03:59Z","timestamp":1790849039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03950-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3950"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03950-9","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The collection of human samples was approved by all patients under written informed consent. This study was conducted in accordance with the Declaration of Helsinki and was approved by the Internal Review and Ethics Committee of the Beijing Tiantan Hospital. The Animal Welfare and Ethics Committee of Beijing Neurosurgical Institute Laboratory approved all animal ethics and protocols.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"332"}}